We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.14 | -6.86% | 1.90 | 1.84 | 1.96 | 2.01 | 2.00 | 2.00 | 1,925,128 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.76 | 6.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/11/2018 12:30 | Boom only need another 6p to be breaking a profit | kirk 6 | |
09/11/2018 14:57 | For any one who is interested Evgen Pharma has results of 2 trials due over the next few weeks, share price is starting to rise in anticipation is up 25% already this week. Currently at 17p pre results broker target is £1.10. | spmc | |
08/11/2018 17:21 | I took off, no buyers to continue to power it. The trend downwards resumes, I am afraid. KoT | king of thieves | |
08/11/2018 15:49 | No placebo group so it will never be unequivocal....or submissable from an efficacy point of view? | nobbygnome | |
08/11/2018 14:32 | Why can't map study be kept going until it becomes unequivocal....one way or another | kop202 | |
08/11/2018 13:45 | >> colsmith But the worry is that they are wasting time and money. The most likely outcome of the MAP is highly equivocal results which get them no further from a regulatory point of view. So what do they do then once they have spent most of the cash. A sensible management team would have realised that they had to change their approach and go back and do a study with a proposer dose. That would require reformulation (unless you just inject a lot more frequently) and another phase II dose ranging study. IMHO that would be a much better use of shareholder funds. | nobbygnome | |
08/11/2018 13:29 | Gabberdemon...nice photo shame about your potty mouth | kop202 | |
07/11/2018 13:04 | Thought long and hard as to whether to reply to your post.As a Pharmacist with 40 years experience I do however think I know enough to comment.Clearly we disagree, I don't have a problem with that. Every patient needs to take ownership of their own condition and medication. | chrisowen | |
07/11/2018 12:59 | Wonder when the cash runs out again, all those lovely BoD salaries getting paid every, month with no doubt a positive spin on the last disastrous RNS to come soon, in time for Xmas/NY hope and merrymaking? | ny boy | |
07/11/2018 12:00 | Nobby re your 33664 - thanks an interesting and clearly thought out dissertation. However, the P3 results justify IMO that getting to market for a longer term use in the so called real world is justified on the results. I believe someone with the disease would be prepared to accept the product for treatment provided their Doctor considered it in their interest; after all with the benign side effects the risk of problems would seem minimal to not existent. Your assessment that a larger dose is likely to be more effective may well justify further work to assess different doses - the 60 or so Q19/results and later MAP results would/should mean this is considered. Q19 will be a pivotal pointing one way or the other based on the experiences of the 60 - such as I would be prepared to continue, its improved my condition, or the alternative. Have a nice day | colsmith | |
07/11/2018 10:42 | Any ideas why the price rise? Quantum tunnelling? Light effects round a black hole? Or.. | glennrcharles | |
07/11/2018 00:30 | A fine short. | ken chung | |
07/11/2018 00:30 | Any news to justify the rise or is it just lemmings and mushrooms mindlessly throwing money away as usual. | ken chung | |
06/11/2018 22:15 | Oh dear a newly joined ADVFN member today! Why do I suspect we are about to get some dubious posts...... | nobbygnome | |
06/11/2018 18:37 | Good shares Looking to sell at 20p. KoT | king of thieves | |
06/11/2018 16:20 | >> stockriser They can inject that drug once every 13 weeks because it is a depo injection, in other words it slowly seeps out over the time period. That is not true for Lupuzor where the half-life is a couple of hours at best and it will certainly be all gone by the end of day one. They cannot even measure it in the blood even straight after the injection because the concentration is so low. That adds up to homeopathy to me..... >> gaberdemon I wish you all good luck for whatever is wrong with you. Lupuzor has zero side effects so I think upping the dose ten fold would not be a problem from that point of view. | nobbygnome | |
06/11/2018 15:51 | Yea maybe the dose was too low for some but enough to give remission in others? | glennrcharles | |
06/11/2018 15:31 | All drugs have side effects, it's a question of balance between the positives and negatives of any particular medication. However to think that the more side effects experienced is directly proportionate to the benefit received is nonsense.Looks like the dose in humans was way too low to hope to be effective though which suggests gross incompetence somewhere. | chrisowen | |
06/11/2018 15:30 | Ok this rise is unexpected......leak | coldspring | |
06/11/2018 15:27 | OEX looking strong again | letmepass | |
06/11/2018 12:24 | Haha, yes, I noticed. I have plenty outbursts, so plenty apologies at the ready. I am poorly myself, so I understand the strife involved with everything, and I understand that low doses are worthless. The disease just gets more evolved. They must up the dose, and the people tested on must not complain, they must think of a way to alleviate the side effects. The more side effects, the better the drug is working IMHO, from personal experience. Obviously, we prefer to have less, but you cant always get what you want perfectly in this life. They should find ways to manage the side effects, such as enemas and supplements, juicing and explaining to patients that they must restrict their diets and practice self control, push past the side effects, drink tons of water, perhaps take niacin to flush the blood daily. To be honest, if someone is so ill, they will not care about side effects, they will ride it out, because death is much more preferable to someone in such pain, rather to continue living. In my opinion, and through my experience. Bacteria is very resistant, and I do hope they realise about acid fast bacilli, this is a monstrous, ever evolving, pretty much invisible, and worrying aspect of disease. If not already, they should take into consideration the old time Kiehl Neelson staining, in studies. I hope they have done this, a big picture, a much needed big picture in all aspects of medical study, could be formed, and the sudden realisation will be magnificent. I could be wrong ;-) | gabberdemon | |
06/11/2018 12:19 | NG - Genuine Question : Depo-Provera (contraceptive injection) most commonly given in the UK lasts for 13 weeks on one injection. Why can't lupuzor have a slow effect over 28 days? | stockriser | |
06/11/2018 11:25 | PS I am happy to act as a consultant for the company to explain all this information to them at a cheap rate of £1000 per day. | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions